AI Analysis AI Analysis of CPHRF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CPHRF to Watchlist?
Some Reasons Why To Add CPHRF:
  • Strong operating margin of 38.8%
  • Healthy interest coverage ratio of 39.0x
  • High gross margin of 74.5%
PDF

Cipher Pharmaceuticals Inc. stock upgraded from Sell Candidate to Buy Candidate after Friday trading session
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jul 31, 2026

The Cipher Pharmaceuticals Inc. stock price gained 3.40% on the last trading day (Friday, 31st Jul 2026), rising from $11.55 to $11.94. During the last trading day the stock fluctuated 3.40% from a day low at $11.55 to a day high of $11.94. The price has fallen in 5 of the last 10 days but is still up by 1.47% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 275 more shares were traded than the day before. In total, 775 shares were bought and sold for approximately $9.26 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.11% during the next 3 months and, with a 90% probability hold a price between $9.74 and $11.67 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CPHRF Signals & Forecast

The Cipher Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $11.68 and $11.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 29, 2026, and so far it has risen 4.86%. Further rise is indicated until a new top pivot has been found. Cipher Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Wednesday, July 29, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Wednesday, July 29, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Cipher Pharmaceuticals Inc. stock

Cipher Pharmaceuticals Inc. finds support from accumulated volume at $11.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.393 between high and low, or 3.40%. For the last week the stock has had daily average volatility of 1.59%.

Our recommended stop-loss: $11.27 (-5.61%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 23 days ago.)

Trading Expectations (CPHRF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Cipher Pharmaceuticals Inc. to open at $11.81, and during the day (based on 14 day Average True Range), to move between $11.85 and $12.03, which gives a possible trading interval of +/-$0.180 (+/-1.52%) up or down from last closing price. If Cipher Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 1.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.43 (4.29%) than the resistance at $12.60 (5.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cipher Pharmaceuticals Inc. will release earnings on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.206. We will update the financials statements for Cipher Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 2.00% in the first trading day after earnings release.

Is Cipher Pharmaceuticals Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.693 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $11.81 ( 1.10%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CPHRF Performance

Trading levels for CPHRF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 12.20 2.19%
R2 12.05 0.94%
R1 11.96 0.160%
Price 11.94
S1 11.66 -2.35%
S2 11.57 -3.13%
S3 11.42 -4.38%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.34 20.08%
R2 13.50 13.04%
R1 12.60 5.51%
Price 11.94
S1 11.43 -4.29%
S2 11.41 -4.46%
S3 11.39 -4.64%

FAQ

What is the symbol for Cipher Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Cipher Pharmaceuticals Inc. is CPHRF and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Cipher Pharmaceuticals Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Cipher Pharmaceuticals Inc. Stock?
Cipher Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cipher Pharmaceuticals Inc. Stock.

What's the current price of Cipher Pharmaceuticals Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Cipher Pharmaceuticals Inc. (CPHRF) share was $11.94.

What is the 52-week high and low for Cipher Pharmaceuticals Inc. Stock?
The 52-week high for Cipher Pharmaceuticals Inc. Stock is $15.00 and the 52-week low is $8.73.

What is the market capitalization of Cipher Pharmaceuticals Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Cipher Pharmaceuticals Inc. is 303.236M.

When is the next earnings date for Cipher Pharmaceuticals Inc.?
The upcoming earnings date for Cipher Pharmaceuticals Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CIPHER PHARMACEUTICALS INC.
Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream tha...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE